Veriheal

JUNE 29, 2022

Consequently, psychedelics have received a significant amount of attention for ailments that are in need of more effective solutions, such as treatment-resistant depression (TRD). Exploring Psilocybin and Treatment-Resistant Depression. Future Trials With COMP360 Psilocybin.

Clinical Trials 103

Clinical Trials Blood Pressure Treatment Therapy 103

Project CBD

AUGUST 6, 2019

Harvard University scientist Staci Gruber shared encouraging results from “the first open-label to double-blind clinical trial” assessing the impact of a high- CBD , low- THC sublingual tincture in patients who experience moderate anxiety. Results highlight the need for expanded patient access to CBD products.”.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

Project CBD

AUGUST 6, 2019

Harvard University scientist Staci Gruber shared encouraging results from “the first open-label to double-blind clinical trial” assessing the impact of a high- CBD , low- THC sublingual tincture in patients who experience moderate anxiety. Results highlight the need for expanded patient access to CBD products.”.

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

Veriheal

SEPTEMBER 6, 2022

During the third stage of sleep, muscles start to relax, and both the blood pressure rate and breathing rate drop. In a systematic review published in 2017 , researchers found that “Preliminary research into cannabis and insomnia suggests that cannabidiol (CBD) may have therapeutic potential for the treatment of insomnia.

Sleep 105

Sleep THC CBD Chronic Pain 105

The Cannigma

DECEMBER 12, 2022

Turning down activity in the DMN allows better access to new areas of the brain, which can boost creativity and improve problem solving. Hallucinations, increased blood pressure, nausea, vomiting, and diarrhea are all common side effects. Clinical research: Research is focusing on 5-MeO-DMT use in depression and anxiety.

History 119

History Microdosing Research and Development Clinical Trials 119